Yahoo Web Search

Search results

1. www.oranomed.comOrano Med | Home

   www.oranomed.com

   • Cached

   Orano Med seeks to develop a new generation of targeted therapies against cancer using the unique properties of lead-212 (212Pb), a rare alpha-emitting radioisotope and one of the most potent therapeutic payloads against cancer cells. Discover our mission.

   • About us

     Orano Med seeks to develop a new generation of targeted...

   • Targeted Alpha Therapy

     Targeted Alpha Therapy relies on a simple concept: combining...

   • Pipeline

     Based on the unique properties of 212Pb, Orano Med is...

   • Industrial platform

     The patented, entirely chemical process, developed by Orano...

   • News

     By clicking “I accept Cookies”, you agree with the cookies...

   • Contact

     Orano Med Contact. By clicking “I accept Cookies”, you agree...

   • Careers

     Orano Med: Orano Med has developed new processes for...

2. People also ask

   What is Orano Med?

   • Orano Med seeks to develop a new generation of targeted therapies against cancer using the unique properties of lead-212 (212Pb), a rare alpha-emitting radioisotope and one of the most potent therapeutic payloads against cancer cells.

   Orano Med | Home

   www.oranomed.com/en

   See all results for this question

   Where is Orano Med manufactured?

   • Orano Med has 212 Pb manufacturing facilities, laboratories, and R&D centers in France and in the US and is currently investing to further expand its GMP-manufacturing capacities for 212 Pb radiolabeled pharmaceuticals in North America and Europe. More information about Orano Med, visit: www.oranomed.com .

   RadioMedix and Orano Med receive FDA Breakthrough Therapy Design…

   www.businesswire.com/news/home/20240212199538/en/RadioMedix-and-Orano-Med-receive-FDA-Breakthrough-Therapy-Designation-for-AlphaMedixTM-in-gastroenteropancreatic-neuroendocrine-tumors

   See all results for this question

   Why did Orano Med receive FDA approval?

   • This recognition from the FDA reinforces Orano Med’s commitment to make innovative lead-212-based therapies available to the medical community and patients worldwide,” said Julien Dodet, President and Chief Executive Officer of Orano Med.

   RadioMedix and Orano Med receive FDA Breakthrough Therapy Design…

   www.oranomed.com/en/resources/news/2024/radiomedix-and-orano-med-receive-fda-breakthrough-therapy-designation-for-alphamedixtm-in-gastroenteropancreatic-neuroendocrine-tumors

   See all results for this question

   What is Orano Med doing with 212 PB?

   • The company is developing several treatments using 212 Pb combined with various targeting agents. Orano Med has 212 Pb manufacturing facilities, laboratories, and R&D centers in France and in the US and is currently investing to further expand its GMP-manufacturing capacities for 212 Pb radiolabeled pharmaceuticals in North America and Europe.

   RadioMedix and Orano Med receive FDA Breakthrough Therapy Design…

   www.businesswire.com/news/home/20240212199538/en/RadioMedix-and-Orano-Med-receive-FDA-Breakthrough-Therapy-Designation-for-AlphaMedixTM-in-gastroenteropancreatic-neuroendocrine-tumors

   See all results for this question

3. www.businesswire.com › news › homeRadioMedix and Orano Med receive FDA Breakthrough Therapy ...

   www.businesswire.com › news › home

   • Cached

   Feb 12, 2024 · Orano Med is a clinical-stage biotechnology company that develops a new generation of targeted therapies against cancer using the unique properties of lead-212 ( 212 Pb), a rare alpha-emitting...

4. www.oranomed.com › en › resourcesRadioMedix and Orano Med receive FDA Breakthrough Therapy ...

   www.oranomed.com › en › resources

   • Cached

   Feb 12, 2024 · RadioMedix, Inc. and Orano Med, two clinical stage radiopharmaceutical companies, today announced that the United States Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to AlphaMedix TM (212 Pb-DOTAMTATE) for the treatment of adult patients with unresectable or metastatic, progressive somatostatin receptor ...

5. www.macrocyclics.com › about › oranomedOrano Med - Macrocyclics

   www.macrocyclics.com › about › oranomed

   • Cached

   Orano Med has developed new processes for producing lead-212 (²¹²Pb), a rare radioactive isotope used in Targeted Alpha Therapy (TAT), an innovative and promising approach of nuclear medicine allowing to recognize and destroy cancer cells while limiting the impact on nearby healthy cells.

6. www.businesswire.com › news › homeRadioMedix and Orano Med Complete Patient Enrolment in Phase ...

   www.businesswire.com › news › home

   • Cached

   May 16, 2023 · Orano Med and RadioMedix announce last patient dosed in the Phase II trial of the targeted alpha emitter therapy, 212Pb-DOTAMTATE (AlphaMedix™).

7. www.orano.group › en › nuclear-expertiseNuclear medicine against cancer | Orano

   www.orano.group › en › nuclear-expertise

   • Cached

   Orano Med, a subsidiary of the Orano Group, is a clinical-stage biotechnology company developing a new generation of targeted cancer therapies based on the unique properties of lead-212 (212 Pb).